Stock Analysts

ABB’s Services for UK Wind Farm

ABB Ltd ( ABB ) has recently received a contract for developing grid connection and providing supporting infrastructure for U.K.-based Vattenfall’s Pen y Cymoedd Wind Energy Project. This wind farm is one of the largest onshore production facilities in England and Wales. The financial value of the deal was not disclosed […]

Stock Analysts

Ericsson’s IMS Solution for TELUS

Leading telecommunications provider Ericsson ( ERIC ) recently announced that it has signed a deal with Canada-based TELUS Corporation ( TU ) to develop and deploy state-of-the-art multimedia services. The financial terms of the deal remain undisclosed. […]

Stock Analysts

Intel to Sell OnCue

According to Bloomberg, Intel Corp. ( INTC ) is looking to sell its yet-to-be-launched online pay-TV service, OnCue and has held talks with potential buyers like Verizon Communications Inc. […]

Stock Analysts

Foster Wheeler Stays Neutral

On Nov 28, we maintained our Neutral recommendation on Foster Wheeler AG ( FWLT ) based on our concerns about the company’s moderate third-quarter earnings performance. The company is expected to benefit from growing demand for energy, and clients will continue to invest in new and upgraded capacity to meet that demand. However, we are concerned about the company’s power segment, which has been witnessing declining revenues due to lower orders […]

Stock Analysts

Update on Merrimack’s MM-121

Merrimack Pharmaceuticals, Inc. ( MACK ) has a license and collaboration agreement with Sanofi ( SNY ) for the development of its oncology candidate, MM-121. Merrimack announced results from two phase II studies evaluating MM-121 for the treatment of women with ER/PR+, HER2 negative breast cancer earlier in the week […]

Stock Analysts

CBS Corp. Maintained at Neutral

On Nov 27, 2013, we reiterated our long-term Neutral recommendation on media conglomerate CBS Corporation ( CBS ) with a target price of $61.50. This was based on the company’s strong third-quarter 2013 results along with strategic initiatives and growth catalysts. However, stiff competition, adverse currency fluctuations and vulnerable advertising revenues pose a serious threat to this Zacks Rank #3 (Hold) stock […]

Stock Analysts

Union Pacific Poised at Neutral

On Nov 27, we maintained our Neutral recommendation on rail transport service provider Union Pacific Corporation ( UNP ). We are encouraged by the company’s growth in chemicals and industrial segments. However, sluggish economic growth, fierce competition and a weak coal business remain causes for concern […]

Stock Analysts

Regency Centers Upgraded to Buy

On Nov 29, 2013, Zacks Investment Research upgraded Regency Centers Corporation ( REG ) to a Zacks Rank #2 (Buy). The upgrade of this retail real estate investment trust (REIT) came on the back of Regency’s solid third-quarter 2013 results and its strong operating fundamentals. […]

Stock Analysts

Positive CHMP Opinion on Glaxo’s Vaccine

GlaxoSmithKline ( GSK ) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion on its cervical cancer vaccine, Cervarix. Glaxo is looking to get a two-dose schedule of Cervarix approved for use in girls between 9 to 14 years for the prevention of premalignant genital lesions including cervical, vulvar and vaginal and cervical cancer causally related to certain oncogenic Human Papillomavirus types. […]

Stock Analysts

IAMGOLD’s Solar Project in Suriname

IAMGOLD Corporation ( IAG ) along with its subsidiary, Rosebel Gold Mines (RGM), will develop and operate a solar power project in Suriname. The project with an installed capacity of 5 megawatts will cost IAMGOLD around $12 million to $14 million, including site access and preparation. IAMGOLD is fulfilling a prior commitment to the Government of Suriname through this green project. […]

Stock Analysts

Aetna Pushed down to Neutral

On Nov 27, 2013, we downgraded our recommendation on Aetna Inc. ( AET ) to Neutral from Outperform; following its third quarter earnings miss, with a 1.96% negative earnings surprise. The health insurer presently carries a Zacks Rank #3 (Hold) […]